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Aging is the accumulation of unrepaired damage to 
cellular and organismal components over time. Damage 
to nuclear DNA likely contributes to the degenerative 
effects of aging; unlike other cellular constituents, 
nuclear DNA cannot be replaced [1]. A wide spectrum 
of DNA lesions and associated repair pathways exist 
[1]: non-helix distorting lesions, such as those induced 
by oxidative damage, are repaired via base excision 
repair (BER); whereas helix-distorting base changes, 
like those caused by UV, are fixed via nucleotide 
excision repair (NER) and its subpathways. DNA 
double strand breaks (DSBs) represent a particularly 
severe challenge to the cell; if left unrepaired these 
lesions can induce cell death, replicative senescence, or 
conversely promote oncogenic transformation. For this 
reason, cells have evolved multiple pathways to repair 
DSBs: classical non-homologous end-joining (C-
NHEJ), homologous recombination (HR), and other 
pathways such as alternative NHEJ [2, 3, 4]. In this 
issue of Aging, work by Chua, McCord et al. suggests 
that SIRT6, a member of a protein family previously 
implicated in promoting longevity, may function at least 
in part via increasing efficacy of DNA repair. 
 
In eukaryotic cells, DNA does not exist as a naked 
double-stranded molecule; rather it is packaged with 
histones and other proteins into a complex structure 
called chromatin [5]. Transcription, replication, and 
repair factors must navigate this environment to interact 
with DNA. Covalent modification of N-terminal histone 
tails (via phosphorylation, methylation, ubiquitination, 
sumoylation, ADP-ribosylation, and acetylation) leads 
to alterations in chromatin function. Chromatin itself 
may serve as a target of age-related change; significant 
alterations in chromatin structure  occur during   senes- 
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cence of mammalian cells in vitro, and perhaps in the 
context of the whole organism as well [5]. One 
consequence of accumulated DNA damage and/or 
chromatin aberrations seems to be age-related perturb-
bations in gene expression in some tissues [5, 6, 7], 
which may in turn lead to progressive loss of cellular 
and organismal homeostasis. However, these trans-
criptional changes are not found in all cell types [8], 
implying that different tissues vary with respect to their 
maintenance of an appropriate gene expression pattern, 
and potentially chromatin structure, with age. 
 
In budding yeast and higher organisms, homologs of the 
Sir2 protein (the sirtuins) link chromatin structure with 
lifespan [9, 10]. In yeast, transcription and recom-
bination of certain regions of the genome – the 
telomeres, the ribosomal DNA array, and the silent 
mating type loci – are down-regulated through the 
action of Sir2 and multiple other factors. Sir2 possess 
histone deacetylase and ADP-ribosyltransferase acti-
vities, both dependent on the metabolic cofactor NAD
+. 
In general, histone deacetylation promotes a more 
compact chromatin structure and inhibits transcription 
and recombination. In yeast, overexpression of Sir2 
increases replicative lifespan – that is, the longevity of a 
single yeast mother cell – whereas deletion of Sir2 
shortens it [11]. Sir2 possesses at least two functions in 
yeast relevant for longevity. First, Sir2 suppresses 
recombination at the repetitive array encoding the 
ribosomal rRNA (the rDNA locus) [5]. HR-mediated 
excision and subsequent replication of extra-
chromosomal rDNA circles is an important cause of 
replicative aging in this organism. Second, Sir2 
regulates the distribution of oxidatively damaged 
proteins [12]. In wild-type cells, oxidized proteins are 
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daughter cell emerges with a complement of 
undamaged proteins and suffers reduced levels of 
oxidative stress; in Sir2 mutants this process fails to 
occur. 
 
A great deal of excitement has emerged from the 
observation that sirtuins in higher organisms are also 
involved in promoting longevity. In C. elegans and D. 
melanogaster, sirtuin overexpression or hyperactivity 
increases lifespan [13, 14, 15]. The mechanisms by 
which sirtuin action increases longevity appear to be 
species-specific; aberrant rDNA recombination has not 
thus far been implicated in limiting lifespan in any 
organism aside from budding yeast. However, in flies, 
Sir2 lies downstream of the histone deacetylase Rpd3 in 
lifespan extension [13], suggesting that, at least in this 
organism, chromatin represents the relevant Sir2 target 
in the context of longevity. 
 
Mammals possess seven sirtuins, called SIRT1-SIRT7 
[16]. Unlike yeast Sir2, which is only known to modify 
histones, mammalian sirtuins have evolved to target a 
plethora of distinct protein substrates, modulating a 
wide variety of biological processes: metabolism, cell 
survival, development, chromatin dynamics, DNA 
repair, and other phenomena [9, 10]. Among sirtuin-
deficient mouse strains, the SIRT6 knockout is 
particularly relevant in the context of the study of aging 
[17, 18]. SIRT6 is found bound to nuclear chromatin 
[18]. In cells, deletion of SIRT6 results in genomic 
instability, manifested as chromosomal breaks and 
fusions, as well as sensitivity to specific genotoxins: the 
alkylating agent methyl methanesulfonate, hydrogen 
peroxide, and ionizing radiation, but not UV. This is a 
spectrum of sensitivities associated with defects in 
BER; indeed, these sensitivities can be rescued via 
introduction of a fragment of polymerase beta (polb), 
the major polymerase involved in “short-patch” BER. 
These observations suggest that SIRT6 might be 
involved in the BER process itself, either by modifying 
BER factors to promote repair or by modulating 
chromatin structure to permit access to DNA lesions. 
No interactions between SIRT6 and BER factors have 
been observed to date however; nor does SIRT6 have an 
apparent role in deacetylating polb itself in vivo [18]. In 
mice, the phenotype of SIRT6 deficiency is dominated 
by metabolic defects [18]. SIRT6 knockout mice are 
born at a Mendelian ratio and, though smaller than 
littermate controls, are fairly normal during the first two 
weeks of life. Subsequently, these mice begin to suffer 
from a complex metabolic/degenerative syndrome, with 
progressive severe hypoglycemia, lymphocytic apop-
tosis and wasting, culminating in death by four weeks of 
age. 
How does the lack of SIRT6 produce such pleiotropic 
effects? It was originally shown that SIRT6 possesses 
ADP-ribosyltransferase activity [18, 19]. More recently, 
Chua, Michishita and colleagues showed that SIRT6 has 
deacetylase activity as well, specifically targeting 
histone H3 on lysine 9 (H3K9) [20]. Knockdown of 
SIRT6 (S6KD) in human cells led to premature 
senescence coupled with genomic instability, although 
the pattern of instability – primarily involving telomeres 
– was distinct from the general instability observed in 
SIRT6-deficient mouse embryonic fibroblasts and ES 
cells [18]. The authors suggested that an altered 
chromatin state at telomeres in S6KD cells due to 
increased levels of acetylated H3K9 prevents 
association of factors required for proper telomere 
maintenance. One of these factors may be WRN, the 
protein defective in Werner syndrome, a disease with 
some manifestations resembling premature aging. Chua 
and colleagues found that WRN’s association with 
telomeric DNA was greatly reduced in S6KD cells. This 
model is unlikely to explain the effects of SIRT6 
deficiency in the mouse, however. The cellular and 
metabolic defects observed in the SIRT6 knockout 
mouse do not resemble those occurring with telomere 
maintenance defects, either in mouse or human, nor do 
they resemble the effects of WRN deficiency in either 
species [21]. The long mouse telomere reserve relative 
to human may explain some of these discrepancies. 
 
In this issue of Aging, Chua, McCord and colleagues 
have now extended their characterization of SIRT6 
function to a more general assessment of the role of this 
factor in DNA repair. They find that the association of 
SIRT6 with chromatin increases following induction of 
DNA damage, whereas overall levels of acetylated 
H3K9 decline in a SIRT6-dependent manner. In human 
cell lines, SIRT6 interacts with DNA-PKcs, a protein 
involved in NHEJ. Chromatin-associated DNA-PKcs 
also increases upon DNA damage in a SIRT6-
dependent manner. In order to define more precisely the 
potential role of SIRT6 at DNA lesions, Chua and 
colleagues employ the meganucleases I-PpoI and I-
SceI, which generate a few hundred DSBs (in the case 
of I-PpoI), or a single DSB following introduction of an 
appropriate site into the human genome (in the case of 
I-SceI). Using these systems, the authors find that 
DNA-PKcs is enriched around the site of a DSB; again 
this effect is dependent upon catalytically active SIRT6. 
Moreover, S6KD cells show defective DSB repair, as 
assessed by comet assay, although repair is normal 
when measured in SIRT6-immunodepleted extracts in 
vitro. The authors suggest that SIRT6 may function to 
deacetylate H3K9 at chromatin surrounding DSBs, 
potentially modulating access for DNA-PKcs and other 
repair factors.  
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organisms implicating sirtuins in DNA repair, as well as 
more recent studies on mammalian SIRT1 (see below). 
In yeast, loss of Sir2 leads to defective NHEJ indirectly, 
via silencing of essential end-joining factors such as 
Nej1 [22]. Loss of the sirtuins Hst3 and Hst4, which 
target acetylated H3K56, promotes genomic instability 
and DNA damage sensitivity [23, 24, 25, 26]. In T. 
brucei, the sirtuin TbSIR2RP1 both deacetylates and 
ADP-ribosylates histones to promote DNA damage 
resistance, associated with increased bulk chromatin 
accessibility [27]. 
 
The study by Chua and colleagues raises a number of 
questions, particularly in light of previous 
characterization of the mouse SIRT6 knockout [18]. 
Mice deficient in DNA-PKcs or other NHEJ factors 
show profound defects in lymphocyte development as a 
consequence of a failure to rejoin RAG-mediated DNA 
breaks generated during immunoglobulin gene 
rearrangement [28]. However, SIRT6-deficient mice 
possess a normal lymphocyte complement prior to the 
onset of apoptosis [18]. Chua et al. suggest that 
lymphocyte-specific factors, such as the RAG proteins 
themselves, may compensate for the lack of SIRT6 
during lymphocyte development. Other explanations are 
conceivable; for example, loss of SIRT6 may confer 
only a partial defect in DNA-PKcs function insufficient 
to impair gross lymphocyte development. One other 
discrepancy between this work and the previous study 
of the SIRT6 knockout concerns the nature of the DNA 
repair defect. While SIRT6-deficient mouse cells do not 
show impaired resolution of DSBs, human S6KD cells 
do demonstrate such a defect. The authors suggest that 
this discrepancy may reflect differing sensitivities of the 
assays used (pulsed field gel electrophoresis in the 
previous work versus comet assay in the current study). 
Equally well, these differences may reflect cell type-
specific and/or species differences in SIRT6 function. 
To resolve these questions, it will be extremely helpful 
to assess SIRT6 and DNA-PKcs recruitment to DSBs, 
as well as DSB repair, in primary mouse cells using 
assays identical to the ones performed by Chua and 
coworkers.  
 
More generally, in order to provide further mechanistic 
detail concerning the functional role of SIRT6 at 
chromatin in the context of DNA repair, it will be 
necessary to determine whether SIRT6 is recruited 
genome-wide in response to DNA damage, or locally, at 
the site of a DSB; as well as to assess the relationship 
between potential local SIRT6 recruitment and acetyl-
H3K9 levels. The data presented do not provide insight 
into these issues. Moreover, in defining the role of 
SIRT6 in DSB repair, it would be helpful to perform 
studies to clarify the kinetics and order of SIRT6 
recruitment relative to DNA-PKcs, as well as the 
kinetics of DSB repair in S6KD cells relative to controls 
(as opposed to testing at a single timepoint). Finally, 
given the data linking SIRT6 to BER function in mouse 
cells, it will be very informative to assess whether 
SIRT6 might promote association of other repair 
factors, such as those involved in BER, to DNA lesions, 
as the authors suggest. 
 
Two recent studies on SIRT1 are relevant to the 
findings of Chua et al. Seto, Yuan and coworkers find 
that SIRT1 deacetylates and activates NBS1, an 
upstream DSB sensor  [29]. More recently, Sinclair, 
Oberdoerffer and colleagues have described a role for 
SIRT1 in DNA repair and age-related alterations in 
gene expression [5]. They find that the association of 
SIRT1 with chromatin, like that of SIRT6, increases in 
response to DNA damage. Under basal conditions, 
SIRT1 is associated with a subset of promoters; 
induction of DNA damage leads to relocalization of 
SIRT1 protein and derepression of many of these SIRT1 
target genes. SIRT1 is required for optimal HR and 
NHEJ, and, consistent with a direct role for SIRT1 at 
sites of DNA breaks, SIRT1 is recruited at these sites 
and is required for optimal recruitment of NBS1 and the 
HR factor RAD51. This function of SIRT1 may be 
important in aging; SIRT1 target promoters are 
derepressed during brain aging, a change blocked by 
overexpression of SIRT1. The authors suggest that over 
the lifetime of the cell, this relocalization of SIRT1 in 
response to DNA damage may lead to age-related 
perturbations in gene expression. Overall, SIRT1 
appears to be involved in both modulating gene 
expression as well as directly recruiting factors to sites 
of DSBs. 
 
These results regarding SIRT1 raise additional 
questions about the role of SIRT6 in DSB repair, and 
organismal homeostasis overall. What is the nature of 
the signal that triggers increased SIRT6 association with 
chromatin in response to DNA damage? ATM kinase 
and histone H2AX, two proteins involved in the DSB 
response, are required for SIRT1 recruitment in this 
context  [5]. Is acetyl-H3K9 the only relevant SIRT6 
target or, like SIRT1, does SIRT6 modify other proteins 
during this process? Could SIRT6 modulate 
transcription of genes relevant for DSB repair, either in 
the basal state or following genomic insult? In this 
context, SIRT6 emerged as a factor required for 
transcriptional repression in a screen for genes involved 
in silencing of the Fas promoter [30]. More recently, a 
study by Chua, Chang, Kawahara and colleagues 
demonstrated that SIRT6 plays a role in attenuating NF- 
κB signaling via H3K9 deacetylation [31]. Thus, SIRT6 
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Acetylated H3K9 is associated with NER [32], a repair 
pathway seemingly not involving SIRT6,  and also 
marks actively transcribed promoters [33]. Thus, it is 
possible that the SIRT6-dependent bulk decrease in 
H3K9 acetylation in response to DSBs observed by 
Chua and colleagues reflects overall transcriptional 
alterations occurring in response to genomic insult, 
instead of or in addition to changes in histone 
acetylation specifically at sites of damage.  
 
Perhaps the most fascinating question in this area 
concerns what the relationship is, if any, between the 
profound metabolic abnormalities of SIRT6 knockout 
animals and the genomic instability conferred by 
reduced levels of SIRT6 in mouse and human cells; 
several models could conceivably explain this 
connection [17]. It has been suggested that the 
organismal effects of SIRT6 deficiency, and similar 
metabolic phenotypes in other repair-deficient mouse 
strains, represent a homeostatic response to minimize 
ongoing genomic damage in the face of a DNA repair 
defect [34]. Such a model would not be consistent with 
the sole DNA repair function of mouse SIRT6 being to 
modulate DNA-PKcs activity, as DNA-PKcs knockout 
animals do not display a dramatic metabolic phenotype 
[1]. Reduction of NF-κB function partially rescues the 
lethality of SIRT6 deficiency [31]; however, survivors 
still suffer a period of depressed serum glucose, 
implying that SIRT6 likely plays other roles in 
metabolism independent of NF-κB. It may be that 
SIRT6 affects transcription at many loci in a tissue-
specific manner; the metabolic defect associated with 
the lack of SIRT6 could represent the net result of 
defective regulation of multiple genes. Clearly, much 
more remains to be learned concerning this fascinating 
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